News about Solvay

  • Local
  • International
  • Company messages
24 Sep
 
19 Sep
 
12 Sep
 
31 Jul
 
25 May
 
22 May
 
11 May
 
08 May
 
03 May
 
11 Apr
 
06 Apr
 
04 Apr
 
29 Mar
 
28 Mar
 
23 Mar
 
20 Mar
 
28 Feb
 
21 Feb
 
16 Feb
 
15 Feb
 

Popular news

1
Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services
2
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers – OPK
3
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
4
Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients
5
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
6
Plexus Celebrates the Opening of the Enhanced Penang Design Center
7
CADWorx® & Analysis Solutions releases new CADWorx Design Review Professional for model visualization and publishing
8
Youth INC and RBC Host Fourth Annual Community Event and Raise $1.7M for NYC Youth
9
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
10
PHILIP MORRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Philip Morris International Inc. - PM

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 September 2018 05:56:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB1 - 2018-09-26 06:56:31 - 2018-09-26 05:56:31 - 1000 - Website: OKAY